glp-1 oral medications FDA approves Foundayo, an alternative to Wegovy and Ozempic A GLP-1 Pill May Help
Description
Distiller, L
:max_bytes(150000):strip_icc()/VWH-GettyImages-2275860768-a6f6e63304e048d0a829844c1dacbd8d.jpg)
In November 2023, the US pharma giant received FDA authorization for Zepbound under the trade name Mounjaro (both tirzepatide), and the drug produced $176 million in revenue over six weeks in 2023
Some people feel nausea, constipation, diarrhea, or fatigue as the dose increases
It also has double-wall insulation to keep your water cold for up to 24 hours
However, these comparisons come from separate trials with different populations and durations
